Insiders · Profile

Smith Nicholas Conrad

PRESIDENT AND CFO at Alto Neuroscience. Filing since 6 Feb 2024. CIK 0002009130

Company
Date
Role
Action
Shares
Amount
Of holding
30 Sep 2026
PRESIDENT AND CFO
Sold at will
24,056
$621.10K
50.0%
29 Sep 2026
PRESIDENT AND CFO
Sold at will
110,830
$2.95M
82.2%
28 Mar 2024
CHIEF FINANCIAL OFFICER
Bought
6,150
$100.63K
29.7%
6 Feb 2024
CHIEF FINANCIAL OFFICER
Bought
1,563
$25.01K
opened
4 decisions on file.